5 Colorectal Cancer Clinical Trials in Chandler, AZ (2026)

Q: How do I join a clinical trial in Chandler?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Chandler research site will contact you.

Recruiting Colorectal Cancer Studies in Chandler

NCT06880055Recruiting

Shield Post-Approval Study Protocol

The Shield post-approval study (PAS) is a prospective, longitudinal study supplemented with Real World Evidence (RWE) to evaluate the longitudinal performance of Shield in an average risk population a...

Chandler, AZ3,375 participantsGuardant Health, Inc.

View Study Details

NCT06445062Recruiting

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON) inhibitors combined with Standard(s) of Care (SOC...

Chandler, AZPHASE11,130 participantsRevolution Medicines, Inc.

View Study Details

NCT06750094Recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

The purpose of this study is to compare how long the participants are disease-free (progression-free survival) and and the length of time until a participant dies (overall survival), when treated with...

Chandler, AZPHASE3700 participantsJanssen Research & Development, LLC

View Study Details

NCT06252649Recruiting

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

The aim of this study is to compare progression free survival (PFS) in treatment-naïve participants with KRAS p.G12C mutated metastatic colorectal cancer (mCRC) receiving sotorasib, panitumumab and FO...

Chandler, AZPHASE3450 participantsAmgen

View Study Details

NCT06562543Recruiting

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

High blood pressure (hypertension) is a known side effect of the treatment with fruquintinib. Current research does not provide a clear answer whether minority groups such as Black/African American an...

Chandler, AZPHASE478 participantsTakeda

View Study Details

About Colorectal Cancer Clinical Trials in Chandler

Colorectal cancer starts in the colon or rectum and is the third most common cancer diagnosed in both men and women. Early detection through screening significantly improves outcomes. Treatments include surgery, chemotherapy, radiation, and targeted therapies.

There are currently 5 colorectal cancer clinical trials recruiting participants in Chandler, AZ. These studies are seeking a combined 5,733 participants. Research is being sponsored by Guardant Health, Inc., Revolution Medicines, Inc., Janssen Research & Development, LLC and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Colorectal Cancer Clinical Trials in Chandler — FAQ

Are there colorectal cancer clinical trials in Chandler?

Yes, there are 5 colorectal cancer clinical trials currently recruiting in Chandler, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chandler?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chandler research site will contact you about next steps.

Are clinical trials in Chandler free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chandler studies also compensate for your time and travel.

What colorectal cancer treatments are being tested?

The 5 active trials in Chandler are testing new therapies including novel drugs, biologics, and treatment approaches for colorectal cancer.

Data updated July 18, 2026 from ClinicalTrials.gov